Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Hematology Oncology Consultants, Inc
mi
from
Columbus, OH
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Hematology Oncology Consultants, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Oncology Consultants
mi
from
Houston, TX
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Oncology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
First Dynamic Healthcare Services, Inc.
mi
from
Killeen, TX
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
First Dynamic Healthcare Services, Inc.
mi
from
Killeen, TX
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Cache Valley Cancer Treatment & Research Clinic, Inc.
mi
from
Logan, UT
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Cache Valley Cancer Treatment & Research Clinic, Inc.
mi
from
Logan, UT
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Virginia Oncology Associates
mi
from
Norfolk, VA
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Western Washington Oncology Inc., P.S.
mi
from
Olympia, WA
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Western Washington Oncology Inc., P.S.
mi
from
Olympia, WA
Click here to add this to my saved trials
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated:  7/29/2015
Ottawa Regional Cancer Centre
mi
from
Ottawa,
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: Enrolling
Updated: 7/29/2015
Ottawa Regional Cancer Centre
mi
from
Ottawa,
Click here to add this to my saved trials
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated:  7/30/2015
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated: 7/30/2015
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated:  7/30/2015
Northeast Georgia Cancer Care
mi
from
Athens, GA
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated: 7/30/2015
Northeast Georgia Cancer Care
mi
from
Athens, GA
Click here to add this to my saved trials
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated:  7/30/2015
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated: 7/30/2015
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated:  7/30/2015
The West Clinic, PC
mi
from
Memphis, TN
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer
Status: Enrolling
Updated: 7/30/2015
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
El Camino Hospital Cancer Center
mi
from
Mountain View, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
El Camino Hospital Cancer Center
mi
from
Mountain View, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Bay Area Breast Surgeons, Incorporated
mi
from
Oakland, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Bay Area Breast Surgeons, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Tom K Lee, Incorporated
mi
from
Oakland, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Tom K Lee, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Doctors Medical Center - San Pablo Campus
mi
from
San Pablo, CA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Doctors Medical Center - San Pablo Campus
mi
from
San Pablo, CA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Boulder Community Hospital
mi
from
Boulder, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Porter Adventist Hospital
mi
from
Denver, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Rose Medical Center
mi
from
Denver, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Swedish Medical Center
mi
from
Englewood, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
North Colorado Medical Center
mi
from
Greeley, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
McKee Medical Center
mi
from
Loveland, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
North Suburban Medical Center
mi
from
Thornton, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Florida Hospital Memorial Medical Center
mi
from
Daytona Beach, FL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Florida Hospital Memorial Medical Center
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Memorial Cancer Institute at Memorial Regional Hospital
mi
from
Hollywood, FL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Memorial Cancer Institute at Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Ella Milbank Foshay Cancer Center at Jupiter Medical Center
mi
from
Jupiter, FL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Ella Milbank Foshay Cancer Center at Jupiter Medical Center
mi
from
Jupiter, FL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
John B. Amos Cancer Center
mi
from
Columbus, GA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
John B. Amos Cancer Center
mi
from
Columbus, GA
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Oncare Hawaii, Incorporated - Pali Momi
mi
from
Aiea, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Oncare Hawaii, Incorporated - Pali Momi
mi
from
Aiea, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center at Pali Momi
mi
from
Aiea, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Queen's Cancer Institute at Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Kuakini Medical Center
mi
from
Honolulu, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Kuakini Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
OnCare Hawaii, Incorporated - Lusitana
mi
from
Honolulu, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Castle Medical Center
mi
from
Kailua, HI
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Castle Medical Center
mi
from
Kailua, HI
Click here to add this to my saved trials
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  7/31/2015
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Phase I/II Study of Panobinostat (LBH589) and Letrozole in Patients With Triple Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 7/31/2015
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials